Safety and efficacy of SITAgliptin plus GRanulocyte-colony-stimulating factor in patients suffering from Acute Myocardial Infarction (SITAGRAMI-Trial) - Rationale, design and first interim analysis

International Journal of Cardiology

Volumn 145, Issue 2, 2010, Pages 282-284

  Theiss, Hans D ^a   Brenner, Christoph ^a   Engelmann, Markus G ^a   Zaruba, Marc Michael ^a   Huber, Bruno ^a   Henschel, Volkmar ^b   Mansmann, Ulrich ^b   Wintersperger, Bernd ^a   Reiser, Maximilian ^a   Steinbeck, Gerhard ^a   Franz, Wolfgang M ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Institute for Medical Informatics Biometry and Epidemiology (IBE)   (Germany)

Author keywords

DPP IV inhibition; G CSF; Myocardial infarction; Sitagliptin; Stem cell homing

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; SITAGLIPTIN;

ACUTE HEART INFARCTION; ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; LETTER; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 78650023641     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.09.555     Document Type: Article

References (17)

1. D. Zohlnhofer, A. Dibra, and T. Koppara Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis J Am Coll Cardiol 51 15 2008 1429 1437
2. D. Zohlnhofer, I. Ott, and J. Mehilli Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial JAMA 295 9 2006 1003 1010
3. M.G. Engelmann, H.D. Theiss, and C. Hennig-Theiss Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (granulocyte colony-stimulating factor ST-segment elevation myocardial infarction) trial J Am Coll Cardiol 48 8 2006 1712 1721
4. H. Ince, M. Petzsch, and H.D. Kleine Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by granulocyte colony-stimulating factor (FIRSTLINE-AMI) Trial Circulation 112 9 Suppl 2005 I73 I80
5. M.G. Engelmann, H.D. Theiss, and C. Theiss G-CSF in patients suffering from late revascularised ST elevation myocardial infarction: final 1-year-results of the G-CSF-STEMI Trial Int J Cardiol 2009
6. D.J. Ceradini, A.R. Kulkarni, and M.J. Callaghan Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 Nat Med 10 8 2004 858 864
7. H.D. Theiss, R. David, and M.G. Engelmann Circulation of CD34+ progenitor cell populations in patients with idiopathic dilated and ischaemic cardiomyopathy (DCM and ICM) Eur Heart J 28 10 2007 1258 1264
8. K.W. Christopherson II, G. Hangoc, and H.E. Broxmeyer Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells J Immunol 169 12 2002 7000 7008
9. M.M. Zaruba, H.D. Theiss, and M. Vallaster Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction Cell Stem Cell 4 4 2009 313 323
10. G.A. Herman, C. Stevens, and K. Van Dyck Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses Clin Pharmacol Ther 78 6 2005 675 688
11. F. Van de Werf, D. Ardissino, and A. Betriu Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 24 1 2003 28 66
12. G.W. Stone, B. Witzenbichler, and G. Guagliumi Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 21 2008 2218 2230
13. A.T. Askari, S. Unzek, and Z.B. Popovic Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy Lancet 362 9385 2003 697 703
14. J.D. Abbott, Y. Huang, D. Liu, R. Hickey, D.S. Krause, and F.J. Giordano Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury Circulation 110 21 2004 3300 3305
15. V.F. Segers, T. Tokunou, L.J. Higgins, C. MacGillivray, J. Gannon, and R.T. Lee Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction Circulation 116 15 2007 1683 1692
16. D.J. Drucker, and M.A. Nauck The incretin system: glucagon-like pedtide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes Lancet 368 2006 1696 1705
17. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2 2009 149 150